The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model
ConclusionsA popPK model utilising weight, albumin, FC, ESR, and the SNP rs1048610 accurately predicted infliximab trough concentrations in children with IBD.
Source: Pediatric Drugs - Category: Pediatrics Source Type: research
More News: Child Development | Children | Gastroenterology | Inflammatory Bowel Disease | Pediatrics | Remicade | Spain Health | Statistics | Study